This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Amryt Pharmaceuticals Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Mark Sumeray: Innovator in Pediatric Hyperlipidemia Treatment
Introduction: Mark Sumeray is a notable inventor based in Zug, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of hyperlipidemia and hypercholesterolemia in pediatric patients. His innovative approach has the potential to improve the health outcomes of children suffering from these conditions.
Latest Patents: Mark Sumeray holds a patent for Lomitapide, which is used in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patients. The patent outlines methods for treating these conditions with lomitapide or a pharmaceutically acceptable salt thereof. This advancement represents a crucial step in pediatric healthcare.
Career Highlights: Throughout his career, Mark has been dedicated to developing effective treatments for challenging medical conditions. His work at Amryt Pharmaceuticals Inc. has allowed him to focus on innovative solutions that address unmet medical needs. His expertise in this area has positioned him as a key figure in pharmaceutical research.
Collaborations: Mark Sumeray has collaborated with talented professionals in the field, including Ruth Nallen and Tracy Cunningham. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion: Mark Sumeray's contributions to pediatric medicine through his patent for Lomitapide highlight his commitment to improving healthcare for children. His work continues to inspire advancements in the treatment of hyperlipidemia and hypercholesterolemia.